Fiche centre
TG Therapeutics Investigational Trial Site
Boston — United States
Essais liés3clinical trials
VilleBostonlocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT06143514
Essais cliniques associés
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| ENABLE — A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS) | SEP | À vérifier | NCT06433752 | ENABLE — A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS) | RECRUITING |
| Ublituximab | SEP | Phase 3 | NCT05877963 | ENHANCE — Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab | RECRUITING |
| PROVIDE — A Study Evaluating the Presence and Concentration of BRIUMVI™ (Ublituximab) in Breast Milk | SEP | À vérifier | NCT06143514 | PROVIDE — A Study Evaluating the Presence and Concentration of BRIUMVI™ (Ublituximab) in Breast Milk | RECRUITING |